Comparative Analysis of the Efficacy and Safety of Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia according to Prostate Size

다국어 초록 (Multilingual Abstract)

Purpose: This study was conducted to perform a comparative analysis of the efficacy and safety of photoselective vaporization of the prostate (PVP) for treatment of benign prostatic hyperplasia (BPH) in men with a prostate volume greater than 60 cc.
Materials and Methods: The clinical data of 249 men with symptomatic BPH who underwent PVP between January 2006 and June 2008 were retrospectively analyzed. All patients were classified into two groups according to their prostate volume (group A, ＜60 cc; group B, ≥60 cc). The preoperative evaluation included a digital rectal exam, urinalysis, prostate-specific antigen levels, International Prostate Symptom Score (IPSS), quality of life (QoL) score, maximal flow rate (Qmax), postvoid residual urine volume (PVR), and transrectal ultrasonography. The total operative time, used energy (kJ), urethral Foley catheter indwelling period, and the number of hospital days were recorded afterward. The IPSS, QoL score, Qmax, and PVR were evaluated at 1, 3, 6, and 12 months postoperatively.
Results: In both groups, significant improvements in the subjective and objective voiding parameters were achieved and these improvements were sustainable for at least 1 year with minimal complications. During the follow-up period, the PVR in group B significantly increased. Retrograde ejaculation and urethral stricture were the common complications in both groups. There was no significant difference in the incidence rate.
Conclusions: PVP is safe and efficacious, with durable results for men with symptomatic BPH and large prostate volumes.

다국어 초록 (Multilingual Abstract)

Purpose: This study was conducted to perform a comparative analysis of the efficacy and safety of photoselective vaporization of the prostate (PVP) for treatment of benign prostatic hyperplasia (BPH) in men with a prostate volume greater than 60 cc.
Materials and Methods: The clinical data of 249 men with symptomatic BPH who underwent PVP between January 2006 and June 2008 were retrospectively analyzed. All patients were classified into two groups according to their prostate volume (group A, ＜60 cc; group B, ≥60 cc). The preoperative evaluation included a digital rectal exam, urinalysis, prostate-specific antigen levels, International Prostate Symptom Score (IPSS), quality of life (QoL) score, maximal flow rate (Qmax), postvoid residual urine volume (PVR), and transrectal ultrasonography. The total operative time, used energy (kJ), urethral Foley catheter indwelling period, and the number of hospital days were recorded afterward. The IPSS, QoL score, Qmax, and PVR were evaluated at 1, 3, 6, and 12 months postoperatively.
Results: In both groups, significant improvements in the subjective and objective voiding parameters were achieved and these improvements were sustainable for at least 1 year with minimal complications. During the follow-up period, the PVR in group B significantly increased. Retrograde ejaculation and urethral stricture were the common complications in both groups. There was no significant difference in the incidence rate.
Conclusions: PVP is safe and efficacious, with durable results for men with symptomatic BPH and large prostate volumes.

참고문헌 (Reference)

1 황춘하, "전립선비대증에서 전립선 용적에 따른 광선택적 전립선기화술의 단기 치료효과 및 합병증 비교분석" 대한비뇨기과학회 48 (48): 826-831, 2007

2 추설호, "전립선비대증에서 KTP 레이저를 이용한 광선택적 전립선 기화술의 치료효과 및 안전성에 대한 결과: 2년 추적관찰" 대한비뇨기과학회 49 (49): 831-836, 2008

3 이종, "전립선 용적이 40cc 이상인 환자에서 고출력 KTP 레이저 전립선기화술 후의 삶의 질 및 효용성 평가" 대한비뇨기과학회 48 (48): 956-964, 2007

4 McAllister WJ, "Vaporization of the prostate" 14 : 31-34, 2004

5 Monoski MA, "Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention" 68 : 312-317, 2006

6 Lee E, "Prevalence of lower urinary tract symptoms in Korean men in a community-based study" 33 : 17-21, 1998

7 Yu X, "Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies" 180 : 241-245, 2008

8 Te AE, "Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial" 172 : 1404-1408, 2004

9 Bachmann A, "Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome" 48 : 965-971, 2005

10 Horasanli K, "Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial" 71 : 247-251, 2008

11 Sandhu JS, "High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates" 64 : 1155-1159, 2004

12 Reich O, "High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients" 173 : 158-160, 2005

13 Ahmed HU, "Greenlight prostatectomy: a challenge to the gold standard? A review of KTP photoselective vaporization of the prostate" 17 : 156-163, 2007

14 Alivizatos G, "Greenlight laser in benign prostatic hyperplasia: turning green into gold" 18 : 46-49, 2008

15 Madersbacher S, "EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)" 46 : 547-554, 2004

16 Rassweiler J, "Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention" 50 : 969-979, 2006

17 Spaliviero M, "Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)" 40 : 529-534, 2008

18 Wasson JH, "A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate" 332 : 75-79, 1995